During the last decade, Fishawack Health has grown both organically and through a well-thought-out buy and build strategy, which has seen our offering for clients to grow to a full-service agency.
Today, we provide comprehensive and cross-functional solutions in medical, consulting and creative, and partner with our clients across the product lifecycle from laboratory to launch and beyond.
We do this so successfully because we operate as a pack, with each acquisition, capability and individual bringing unique skills to the group. Together we unite across organisations, teams and countries to deliver exceptional work for our clients.
Our coverage in MM&M’s 2020 Agency 100, which lists the top 100 agencies in North America, exemplifies the strength of our capabilities.
Our creative agency Carling Communications, our digital and media experts 2e Creative, and our rare disease specialists Dudnyk were all listed in the top 100 agencies. Meanwhile, James Atherton, U.S. Managing Director at our strategic consultancy Blue Latitude Health, featured in heavily in the publisher’s ‘Growth Spurt’ editorial.
This year the Fishawack Health team achieved some incredible wins, including our largest win to date –Janssen’s multiple myeloma Portfolio (Darzalex and CAR-T therapy).
Fishawack Health US President Sherri Wilkins explains how the strength of our united offering has helped the account grow from strength to strength: “We were able to take the mix of creative, digital, consulting and strategy that we had across our group and build a team that answers all of the client’s needs, versus the client having to go identify a digital partner and a consumer partner and more.”
Carling Communications has now successfully integrated into the Fishawack Health brand. The team’s innovative, unique mindset and skills ensure we deliver exceptional and impactful creative campaigns for our clients.
Contact us to find out how we can develop tailored teams to solve your, strategic, medical or commercial challenges.